Gå direkte til innhold
 

Joint call for proposals: Norwegian-Indian collaboration on human vaccination research 2007

Forskerprosjekt Velg
Brukerstyrt innovasjonsprosjekt Velg
Kompetanseprosjekt med brukermedvirkning Velg
Søknadsfrist:
06.06.2007 18:00 CEST

Status:

Gjennomført

Antatt tilgjengelige midler:

AVAILABLE FUNDING, APPLICATION DEADLINE AND PROJECT START DATE:
Application deadline is June 6th 2007 at 18:00 hrs (Norwegian time). Earliest possible start of projects is November 1st 2007. Projects should run over a period of 3-4 years, and must be completed by the end of 2011. A maximum allocation of 30 mill. NOK (USD 5 million) will be available from GLOBVAC to fund the activities proposed by the Norwegian investigator(s), while costs proposed by the Indian investigator(s) will be provided by the Department of Biotechnology (DBT), India.

The funding from GLOBVAC will be allocated from the overall larger call of 100 mill. NOK, and applications will be seen in association with this overall call.

Føringer og viktige forhold for alle søknadstyper i utlysningen:


PREAMBLE:

The Department of Biotechnology (DBT), Ministry of Science & Technology, Govt. of India and The Research Council of Norway (RCN) intend to initiate collaborative efforts between India and Norway in the field of human vaccination research. Keeping this in view, key meetings were held between Indian and Norwegian stakeholders in Bergen and New Delhi during 2006. These efforts have yielded a The embedded asset has been deleted:
Asset Type: Vedlegg_flex
Asset Id: 1177351237552
PAGENAME: ForskningsradetNorsk/Vedlegg_flex/Vedlegg_TittelLenke
on Indo-Norwegian collaboration in vaccination research, and the collaboration on human vaccination is part of the GLOBVAC programme as described in the The embedded asset has been deleted:
Asset Type: Vedlegg_flex
Asset Id: 1177351247813
PAGENAME: ForskningsradetNorsk/Vedlegg_flex/Vedlegg_TittelLenke
. The roadmap sets out guiding principles of the proposed collaboration, but the call for proposals are not limited to those institutions or companies mentioned in this document. Accordingly, proposals from the investigators-driven research initiatives with interactive collaborative efforts across institutions and disciplines in areas of human vaccination research, are invited. Under this proposed collaborative effort, both RCN and DBT plan to provide financial support to promote development of the vaccination sector in India and Norway. This will also create a foundation on which the two countries may cooperate on marketing new discoveries and related product/process development. Collaborative research components may comprise both basic and applied research. This call will include researcher projects -  link but also business and industry involvement through knowledge-building projects with user involvement -  link and user-driven innovation research projects -link. This initiative will ensure the implementation of a number of projects that encompass collaboration between different institutions and disciplines (platform projects), with a view to promote optimal knowledge, skill development and appropriate platform for technology promotion and dissemination to the end users benefiting both countries.

THEMATIC GUIDELINES:

The proposal must be within the field of global vaccination research, which is here defined as research aiming at providing existing and improved vaccines for marginalized populations, especially children, in low- and middle-income countries. This includes epidemiological studies, the development and evaluation of new or improved vaccines, implementation of vaccination strategies, and studies to measure the costs and outcomes of such strategies.

This call will encourage, but is not restricted to, proposals focusing on:

  • diseases and health problems that account for a large proportion of the global disease burden
  • diseases and health problems that are neglected
  • thematic areas where Norway and India are strongly involved in health programmes and research
  • thematic areas where Norway and India have the capacity and competence to be in the international forefront
  • thematic areas where synergy effects between Norway and India can be expected

Examples of relevant thematic areas are HIV/AIDS, respiratory and enteric infections, tuberculosis, influenza, meningococcal disease and human papilloma virus (HPV).

The following types of studies are included in this call:

  • development of diagnostic tools, and identification of the need for vaccination programmes based on epidemiological studies
  • development of new candidate vaccines and identification of optimal formulations and immunization regimens for new and existing vaccines
  • development of methods to assess vaccine-induced protection (immune correlates), toxicity and side-effects
  • determination of impact of vaccination, including protective efficacy and effectiveness for relevant outcome parameters and the development of national surveillance systems
  • increasing the availability and ensuring equitable coverage of existing vaccines
  • stimulation of technology transfer to low- and middle-income countries, including improved strategies for cost-effective production of vaccines and the development of trial sites

HOW TO APPLY

The Norwegian and Indian collaborating investigators are required to prepare a joint application for the main research project. Applications should be submitted to both the RCN and the DBT. The applications to RCN should be submitted via the eSøknad electronic application system (follow orange link "Opprett ny søknad" at the bottom of this page).  The applications to the DBT should be submitted electronically (6 copies also by post) on Indian application form, to Mr. S. Sinha:  ssinha.dbt@gmail.com (DBT website: www.dbtindia.gov.in ). All relevant points of the application forms must be completed. The application to the RCN and to DBT should contain an identical project description, describing both the Indian and the Norwegian activities in the project, an overview of proposed annual and overall expenses associated with Norwegian and Indian project activities as well as a funding plan specifying Norwegian and Indian funding sources respectively. All applications submitted to the RCN will be subject to the Council's general rules regarding the application types in question, and the DBT will follow its own norms and procedures.


TIME LINE AND BUDGET

Projects should run over a period of 3-4 years, and must be completed by the end of 2011. Earliest possible start of projects is November 1st 2007. A  maximum allocation of 30 mill. NOK (USD 5 million) will be available from GLOBVAC to fund the activities proposed by the Norwegian investigator(s), while costs proposed by the Indian investigator(s) will be provided by the Department of Biotechnology (DBT), India.
The Indian side will initially grant funding for a period of 3 years, with the possibility for a one year extension.

 


PROPOSAL SUBMISSION

For the Indian side, proposal require to be sent to S. Sinha, Adviser, Department of Biotechnology, Block-II, CGO Complex, Lodhi Road, New Delhi 110003 by e-mail (ssinha.dbt@gmail.com) and also by post (6 copies). For further query/clarification, please contact at Tel. 011-24363760. Website: www.dbtindia.gov.in.

For the Norwegian side, proposals should be submitted using the electronic application form "eSøknad" (follow orange link "Opprett ny søknad" at the bottom of this page). The deadline for submission is June 6th 2007, 18:00 hrs (Norwegian time).


REVIEW PROCESS

All grant applications will be reviewed by international referees. The RCN and the DBT will jointly select up to five international experts to assess grant proposals. The RCN is responsible for circulating joint applications to international experts for review. The RCN's forms and guidelines for international review of grant proposals will be utilised in the assessment process. The RCN and the DBT will evaluate the utility and relevance of applications and agree on which applications to present to the decision-making bodies, with recommendations for whether to grant/deny funding.
In Norway, the applications will be dealt with by The Research Council (i.e. the programme board for Global health and vaccination research (GLOBVAC)), which is responsible for allocating funds / denying the Norwegian part of the application. In India the applications will be processed by the DBT which is responsible for allocating funds / denying the Indian part of the application. Agreement among the decision-making bodies of the two countries is a prerogative for funding common projects.

AWARD CRITERIA

The main criteria for award decision will primarily include the following:

  1. Scientific merit of the project
  2. Expertise with the Principal Investigator(s) and networking/collaborating team
  3. Competence to enter into collaborative arrangements
  4. Availability of core infrastructure and support facilities to carry out the proposed project at host institute(s)
  5. Utility and relevance (for the guidelines of this call)
  6. Strategic use of the funding and the probability for success

Specific criteria are specified in the guidelines for each application type.


ADDITIONAL INFORMATION

Contracts

The RCN will enter into a contract with the Norwegian applicant for the Norwegian share of the project. Likewise, DBT will enter into a contract with the Indian applicant for the Indian share of the project.


Agreement on rights to and use of findings

Before entering into a contract, the concerned parties shall sign an agreement specifying the rights to and use of findings (IPR) in consultation with DBT and RCN.

Time line
Receipt of proposals:    June 6th 2007, 18:00 hrs Norwegian time
Award decision:   September-October, 2007
Award notification:   October - November, 2007

Guidelines for Norwegian partners

Eligible Norwegian applicants are public and private Norwegian institutions. Allocation of funds must contribute to developing high quality projects with participation of Norwegian research environments.

Proposals should include considerations on ethics, capacity building and sustainability.

Normally, projects can have budgets with 1-5 million NOK annually funded from GLOBVAC. Projects are encouraged to secure additional funding from other sources (eg. EU-funding, own funding). Further, projects are encouraged where own/additional funding can be shown to lead to sustainable commitments from own institution or other sources beyond the duration of the project.

The scope of the project should be realistic within the time frame and budget limitations of the project. Project activities should be clearly described according to a timeline. Budget information should be clearly written and detailed.

Recruitment of students, PhD and post doctoral fellows should be integral components of the larger project proposal.


Proposal guidelines and evaluation

  • The application form and project description (a maximum of 10 pages, font Times New Roman 12 point, footnotes and references included) must be written in English
  • All international cooperation must be documented
  • Proposals will be evaluated as described above

Proposals must be on the format of one of the following application types: Researcher project, User-driven innovation project or Knowledge-building project with user involvement. Proposals must follow the criteria as specified in the guidelines for the relevant application type.